Zhou HH - Search Results

1

Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.

Liu HL, Lin YG, Wu J, Sun H, Gong ZC, Hu PC, Yin JY, Zhang W, Wang D, Zhou HH, Liu ZQ. Liu HL, et al. Among authors: zhou hh. Eur J Clin Pharmacol. 2008 Jul;64(7):663-71. doi: 10.1007/s00228-008-0483-9. Epub 2008 Apr 26. Eur J Clin Pharmacol. 2008. PMID: 18438653

2

No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activity.

Xie HG, Xu ZH, Huang SL, Liu JH, Wu JX, Jiang CH, Zhou HH. Xie HG, et al. Among authors: zhou hh. Zhongguo Yao Li Xue Bao. 1997 May;18(3):216-8. Zhongguo Yao Li Xue Bao. 1997. PMID: 10072936 Free article.

3

Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes.

Xu ZH, Wang W, Zhao XJ, Huang SL, Zhu B, He N, Shu Y, Liu ZQ, Zhou HH. Xu ZH, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1999 Sep;48(3):416-23. doi: 10.1046/j.1365-2125.1999.00023.x. Br J Clin Pharmacol. 1999. PMID: 10510155 Free PMC article.

4

Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects.

Qin XP, Xie HG, Wang W, He N, Huang SL, Xu ZH, Ou-Yang DS, Wang YJ, Zhou HH. Qin XP, et al. Among authors: zhou hh. Clin Pharmacol Ther. 1999 Dec;66(6):642-6. doi: 10.1016/S0009-9236(99)90075-9. Clin Pharmacol Ther. 1999. PMID: 10613621

5

Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.

Ou-Yang DS, Huang SL, Wang W, Xie HG, Xu ZH, Shu Y, Zhou HH. Ou-Yang DS, et al. Among authors: zhou hh. Br J Clin Pharmacol. 2000 Feb;49(2):145-51. doi: 10.1046/j.1365-2125.2000.00128.x. Br J Clin Pharmacol. 2000. PMID: 10671909 Free PMC article. Clinical Trial.

6

Ethnic differences in drug metabolism.

Zhou HH, Liu ZQ. Zhou HH, et al. Clin Chem Lab Med. 2000 Sep;38(9):899-903. doi: 10.1515/CCLM.2000.131. Clin Chem Lab Med. 2000. PMID: 11097347 Review.

7

Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy.

Liu ZQ, Wildhirt SM, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Zhongguo Yao Li Xue Bao. 1999 Nov;20(11):1052-6. Zhongguo Yao Li Xue Bao. 1999. PMID: 11270974 Free article. Review.

8

Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.

Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH. Wang JH, et al. Among authors: zhou hh. Clin Pharmacol Ther. 2001 Jul;70(1):42-7. doi: 10.1067/mcp.2001.116513. Clin Pharmacol Ther. 2001. PMID: 11452243

9

Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects.

Liu ZQ, Cheng ZN, Huang SL, Chen XP, Ou-Yang DS, Jiang CH, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Br J Clin Pharmacol. 2001 Jul;52(1):96-9. doi: 10.1046/j.0306-5251.2001.01402.x. Br J Clin Pharmacol. 2001. PMID: 11453896 Free PMC article.

10

Determination of fluoxetine and its metabolite norfluoxetine in human liver microsomes by reversed-phase HPLC in vitro.

Liu ZQ, Cheng ZN, Wang W, Tan ZR, Ou-Yang DS, Zhou HH. Liu ZQ, et al. Among authors: zhou hh. Acta Pharmacol Sin. 2000 Nov;21(11):1027-30. Acta Pharmacol Sin. 2000. PMID: 11501058 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters